AMY ELLSWORTH: Open Payments
NPI 1174711436 · DEL MAR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 63 payments from 16 companies in 2025. Trend: 2023 $827 · 2024 $1,335 · 2025 $1,320
Food & beverage: $1,220Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $355 |
| ABBVIE INC. | 20 | $280 |
| Amgen Inc. | 11 | $207 |
| Incyte Corporation | 5 | $109 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| PFIZER INC. | 2 | $51 |
| STRATA Skin Sciences, Inc. | 1 | $28 |
| UCB, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
Products named: TREMFYA, Otezla, BOTOX, OPZELURA, ILUMYA, SKYRIZI, DUPIXENT, CIBINQO.
Industry payments across CA — which companies pay providers there.
